Questions? +1 (202) 335-3939 Login
Trusted News Since 1995
A service for auto industry professionals · Monday, July 8, 2024 · 726,048,871 Articles · 3+ Million Readers

Global Protein Therapeutics Market: Advancements in Biotechnology and Targeted Treatments Drive Growth

Emergen Research Logo

Emergen Research Logo

Discover the latest trends in the global protein therapeutics market, driven by biotechnological advancements and rising demand for targeted treatments

VANCOUVER, BC, CANADA, July 8, 2024 /EINPresswire.com/ -- The global protein therapeutics market size was USD 152.28 Billion in 2022 and is expected to register a rapid revenue CAGR of 7.6% during the forecast period. The global protein therapeutics market is experiencing substantial growth, driven by increasing demand for targeted treatments and rapid advancements in biotechnology and genetic engineering. Key factors contributing to this growth include the expanding application of protein therapies in addressing cancer, autoimmune diseases, and genetic abnormalities. These therapies are proving effective in treating a spectrum of illnesses, supported by notable collaborations such as the partnership between Nurix Therapeutics and Seagen Inc. to develop Degrader-Antibody Conjugates for cancer treatment.

To avail Sample Copy of the report @https://www.emergenresearch.com/request-sample/2782

Advancements in genetic engineering and biotechnology are pivotal, enabling the development of novel protein-based treatments that are both potent and specific. This innovation is crucial given the rising prevalence of chronic diseases like cancer, diabetes, and cardiovascular diseases, particularly among the elderly population globally.

The market's revolution in protein therapeutics development has led to the production of highly effective medicines. For instance, monoclonal antibodies, a dominant segment in the market, are widely used in treating chronic disorders such as cancer due to their immune system protein properties.

However, despite these advancements, the market faces challenges such as stringent regulatory requirements and high development costs. The complexity of regulatory standards and the need for skilled professionals pose barriers to market growth. Additionally, the substantial costs associated with manufacturing and development hinder broader adoption of protein therapeutics.

Segment-wise, monoclonal antibodies hold the largest market share, owing to their availability and applicability across various chronic conditions. The insulin segment, although growing moderately, is crucial in managing diabetes mellitus.

Request Customization In The Report @https://www.emergenresearch.com/request-for-customization/2782

In terms of deployment, metabolic disorders, particularly diabetes, dominate the market due to the demand for effective therapies. Pharmaceutical companies lead in end-use segments, driving market growth by leveraging protein-based medications for specialized treatments.

Looking ahead, the global protein therapeutics market is poised for steady growth as biotechnology continues to evolve and as pharmaceutical companies expand their research and development efforts. The focus remains on developing more effective and targeted therapies to meet the growing healthcare demands worldwide.

Protein Therapeutics Top Companies and Competitive Landscape

The global protein therapeutics market is fairly fragmented with many large and medium-sized players accounting for majority of market revenue. Major players are deploying various strategies, entering into mergers & acquisitions, strategic agreements & contracts, developing, testing, and introducing more effective protein therapeutics solutions.

Some major players included in the global protein therapeutics market report are:

Eli Lilly and Company.

Johnson & Johnson Services, Inc.

Pfizer Inc.

Boehringer Ingelheim International GmbH.

Kyowa Kirin Co., Ltd.

Generex Biotechnology Corp.

Genentech, USA Inc.

Bristol-Myers Squibb Company

Abbott

Amgen Inc.

Browse The Full Protein Therapeutics Market Report Description, Along With The Tocs And List Of Facts And Figures @ https://www.emergenresearch.com/industry-report/protein-therapeutics-market

Protein Therapeutics Latest Industry News

On 22 October, 2021, Bosch Packaging Technology, a division of Robert Bosch GmbH, introduced the MLF 5088, a new filling and closing machine for pharmaceutical vials. This machine is intended to be used in pharmaceutical production plants, where it provides excellent precision and flexibility in filling and sealing vials of various sizes and varieties.

Protein Therapeutics Market Segment Analysis

For the purpose of this report, Emergen Research has segmented the global protein therapeutics market on the basis of product, application, function, end use, and region:

Product Outlook (Revenue, USD Billion; 2019-2032)

Monoclonal antibodies

Insulin

Fusion protein

Erythropoietin

Interferon

Human growth hormone

Others

Application Outlook (Revenue, USD Billion; 2019-2032)

Metabolic disorders

Immunologic disorders

Hematological disorders

Cancer

Hormonal disorders

Others

Function Outlook (Revenue, USD Billion; 2019-2032)

Vaccines

Protein diagnostics

Enzymatic

Others

End-use Outlook (Revenue, USD Billion; 2019-2032)

Pharmaceutical companies

Research organizations

Healthcare service providers

Academic research institutes

Regional Outlook (Revenue, USD Billion; 2019–2032)

North America

U.S.

Canada

Europe

Germany

France

UK

Italy

Spain

Benelux

Russia

Rest of Europe

Asia Pacific

China

Japan

South Korea

India

ASEAN Countries

Oceania

Rest of APAC

Latin America

Brazil

Mexico

Rest of LATAM

Middle East & Africa

GCC Countries

Israel

Turkey

South Africa

Rest of Middle East & Africa

Click Here To Buy Now @https://www.emergenresearch.com/select-license/2782

Thank you for reading our report. For further information regarding the report or to get a customized copy of it, please connect with us. We will make sure you receive a report perfectly tailored to your needs.

Latest Published Reports by Emergen Research:

Agricultural Robotics Market

https://www.emergenresearch.com/industry-report/agricultural-robotics-market

Plastics Recycling Market

https://www.emergenresearch.com/industry-report/plastics-recycling-market

Gourmet Salt Market

https://www.emergenresearch.com/industry-report/gourmet-salt-market

Incident and Emergency Management Market

https://www.emergenresearch.com/industry-report/incident-and-emergency-management-market

Ultrafiltration Membranes Market

https://www.emergenresearch.com/industry-report/ultrafiltration-membranes-market

Photodynamic Therapy Market

https://www.emergenresearch.com/industry-report/photodynamic-therapy-market

Aircraft Seals Market

https://www.emergenresearch.com/industry-report/aircraft-seals-market

Polyaryletherketone Market

https://www.emergenresearch.com/industry-report/polyaryletherketone-market

Space Robotics Market

https://www.emergenresearch.com/industry-report/space-robotics-market

Martech Market

https://www.emergenresearch.com/industry-report/martech-market

About Us:

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Eric Lee
Emergen Research
+91 90210 91709
sales@emergenresearch.com
Visit us on social media:
Facebook
X
LinkedIn

Powered by EIN Presswire
Distribution channels: Healthcare & Pharmaceuticals Industry


EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.

Submit your press release